JANX Janux Therapeutics, Inc. logo

JANX Janux Therapeutics, Inc.

Healthcare
$14.40-0.83%ClosedMarket Cap: $878.2M

As of 2026-05-26

Institutional Ownership Summary

Investors Holding

188

13F Shares

62,204,999

Ownership %

100.3%

New Positions

46

Increased Positions

114

Closed Positions

42

Reduced Positions

41

ETF Exposure
ETF SymbolETF NameShares HeldWeight %
IDNAiShares Genomics Immunology and Healthcare ETF86,8770.78%
BBCVirtus Biotech Clinical Trials ETF17,8210.71%
FMEDFidelity Disruptive Medicine ETF18,8090.45%
CANCTema Oncology ETF50,8560.42%
XBI1,424,5400.27%
LABUDirexion Daily S&P Biotech Bull 3X ETF71,2540.19%
IBBiShares Biotechnology ETF392,3490.07%
IWNiShares Russell 2000 Value ETF246,1380.03%
BBSCJPMorgan BetaBuilders U.S. Small Cap Equity ETF15,1170.03%
NAJ246,1380.03%
VTWV21,1540.03%
VSEQX166,2870.02%
VSTCX36,9910.02%
NJM1,052,5390.02%
IWMiShares Russell 2000 ETF1,052,5390.02%
SMLFiShares U.S. Small-Cap Equity Factor ETF48,3370.02%
RSSLGlobal X - Russell 2000 ETF19,5890.02%
VTWO212,6110.02%
SCHASchwab U.S. Small-Cap ETF233,4630.02%
VEXRX189,9850.01%